Robert A. Zlotecki, MD, PhD
Articles
Infusional Chemoradiation for Operable Rectal Cancer: Post-, Pre-, or Nonoperative Management?
March 1st 1997Dr. Rich presents a comprehensive overview of adjuvant therapy for advanced operable rectal cancer. He emphasizes the roles of infusional chemoradiation in both the adjuvant setting and as sole therapy. Unless otherwise specified, the following comments pertain to clinically resectable B2-C (T3, N0-N1) adenocarcinoma of the rectum.
Latest Updated Articles
Published: September 13th 2024 | Updated: November 25th 2024
Non–clear Cell RCC: First-Line Treatment Options and Guideline Updates
Published: August 9th 2024 | Updated: August 14th 2024
Gene Assay May Predict Extended Letrozole Benefits in Breast Cancer Subsets
Published: June 2nd 2024 | Updated: June 3rd 2024
OS Prolonged With Perioperative Chemo Vs Neoadjuvant CRT in Esophageal Cancer
Published: May 6th 2024 | Updated: May 21st 2024
FDA Accepts BLA for Subcutaneous Nivolumab in Solid Tumor Indications
Published: May 17th 2013 | Updated: December 22nd 2024
Lower Back Pain in an Elderly Man With a History of Localized Prostate Cancer
Published: December 1st 2016 | Updated: December 22nd 2024
Patient With History of COPD Presents With Abdominal Pain
